1015 Capital Partners »

Regeneron Pharmaceuticals shares owned by 1015 Capital Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by 1015 Capital Partners from 13F filings

Historical chart of 1015 Capital Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by 1015 Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by 1015 Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $12k 16 772.63
2025-12-31 $12k 16 771.88

More positions owned by 1015 Capital Partners

Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Vanguard Total Stock Market Etf Etf (VTI)
Nvidia Corporation Stock (NVDA)
Ishares Short-term National Muni Bond Etf Etf (SUB)
Ishares Core S&p Small Cap Etf Etf (IJR)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
State Street Spdr S&p 500 Etf Etf (SPY)
Vanguard High Dividend Yield Index Etf Etf (VYM)
Ishares Msci Eafe Etf Etf (EFA)
Jpmorgan Municipal Etf Etf (JMUB)
Jpmorgan International Research Enhanced Equity Etf Etf (JIRE)
Ishares Core Msci Eafe Etf Etf (IEFA)
State Street Spdr S&p Dividend Etf Etf (SDY)
Ishares Esg Msci Kld 400 Etf Etf (DSI)

View all positions for 1015 Capital Partners

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
Vanguard Capital Management
State Street Corporation
Dodge & Cox
Franklin Resources
Geode Capital Management
FMR
Nuveen
Loomis, Sayles and
Invesco
Vanguard Portfolio Management
Goldman Sachs Group
Capital World Investors
Susquehanna International

View all funds holding Regeneron Pharmaceuticals